Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells

Gemcitabine-based chemotherapy has been widely adopted as the standard and preferred chemotherapy regimen for treating advanced pancreatic cancer. However, the contribution of multidrug resistance protein 5 (MRP5) to gemcitabine resistance and pancreatic cancer progression remains controversial. In...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ji, Bugde, Piyush, Li, Jiawei, Biswas, Riya, Li, Siting, Yang, Xuewei, Tian, Fang, Wu, Zimei, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696546/
https://www.ncbi.nlm.nih.gov/pubmed/37975256
http://dx.doi.org/10.3892/or.2023.8666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696546/
https://www.ncbi.nlm.nih.gov/pubmed/37975256
http://dx.doi.org/10.3892/or.2023.8666

Ejemplares similares